IgM‐enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices-Reference-Cited by-同舟云学术

IgM‐enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices

Published:2022-07-19 Issue:5 Volume:9 Page:3630-3635
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Immohr Moritz Benjamin¹^ORCID,Böttger Charlotte¹,Aubin Hug¹,Westenfeld Ralf²,Oehler Daniel²,Bruno Raphael Romano²,Dalyanoglu Hannan¹,Tudorache Igor¹,Akhyari Payam¹,Lichtenberg Artur¹,Boeken Udo¹^ORCID

Affiliation:

1. Department of Cardiac Surgery Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf Düsseldorf Germany

2. Division of Cardiology, Pulmonology and Vascular Medicine Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf Düsseldorf Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.14074

Reference15 articles.

1. Twelfth Interagency Registry for Mechanically Assisted Circulatory Support Report: Readmissions After Left Ventricular Assist Device

2. Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation

3. Outcomes of patients with infection related to a ventricular assist device after heart transplantation

4. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report — 2021; Focus on recipient characteristics

5. Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study